Synthetic Biology
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$1.4M
1 round on record
Latest round
$1.4M
Venture round · Apr 2025 · 18 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
18 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2025 | $1.4M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Florey Biosciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Andres Cubillos RuizExecutive Officer, DirectorSEC Form D
Raphael GayetExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Early detection. Smarter farming. Healthier planet. We use synthetic biology to turn invisible plant stress signals into visible early…

Transforming pharmaceutical supply chains using synthetic biology, to end drug shortages and unlock new opportunities in development and…

IMicrobes: Accelerating the transition to sustainable materials through synthetic biology -Our programmable microbes turn ethanol into…

StrainX Bioworks is a next-generation synthetic biology company engineering microbial strains and precision fermentation to produce…

Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the…

Infrastructure and intelligence for bioprocess — for development and manufacturing teams at biopharma, synthetic biology, and CDMOs.
Overview
Florey is a Boston-based company that uses synthetic biology to create and improve beneficial micro-organisms for human health.
People

Andres Cubillos Ruiz
Executive Officer, Director

Raphael Gayet
Executive Officer

Peter Hutt
Director

Mark Smith
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United States
HQ
50-200 est. staff
Financials
Total raised
$1.4M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $1.4M | Details |






